Abbott Laboratories
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Asset Breakdown FY2017
Total Assets: $76.25B
Liabilities Breakdown FY2017
Total Liabilities: $45.35B
Asset Breakdown
Total Assets: $76.25B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.41B | 12.3% |
| Accounts Receivable | $5.25B | 6.9% |
| Inventory | $3.60B | 4.7% |
| Property, Plant & Equipment | $7.61B | 10.0% |
| Goodwill | $24.02B | 31.5% |
| Intangible Assets | $21.47B | 28.2% |
| Other Assets | $4.89B | 6.4% |
Liabilities Breakdown
Total Liabilities: $45.35B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.40B | 5.3% |
| Long-Term Debt | $27.21B | 60.0% |
| Other Liabilities | $15.74B | 34.7% |